The United Laboratories International (HKG:3933) plans to repurchase up to HK$200 million of its shares on the open market under a shareholder-approved mandate, according to a Thursday Hong Kong bourse filing.
The company said the buyback will be funded by internal cash resources, and shares repurchased under the plan will be canceled.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments